VIVET THERAPEUTICS ANNOUNCES 2 ORAL PRESENTATIONS AND 4 ABSTRACTS AT 2021 ESGCT ANNUAL MEETING
VIVET THERAPEUTICS ANNOUNCES 2 ORAL PRESENTATIONS AND 4 ABSTRACTS AT 2021 ESGCT ANNUAL MEETING
Vivet CDO, Anne Douar, presenting during SFTCG webinar on Gene Therapy for Wilson Disease
Vivet CDO, Anne Douar, will be presenting
Vivet Announces Multiple Projects Update, Including New VTX-803 Preclinical data To Be Presented At 2021 ASGCT Annual Meeting
Vivet Therapeutics Announces Multiple Projects Update, Including New VTX-803 Preclinical data To Be Presented At 2021 American Society Of Gene And Cell Therapy Annual Meeting
VIVET ATTENDING ARM 2021 CELL & GENE MEETING ON THE MED
Jean-Philippe Combal, Vivet CEO, will be attending a panel during the Cell & Gene Meeting on the Med – virtual, organized by the ARM on April 6-9, 2021. The panel, “TRENDS AND CHALLENGES IN GENE THERAPY IN EUROPE”, will be held on April 7, 3-4pm CET.
VIVET ATTENDING JEFFERIES 2020 VIRTUAL LONDON HEALTHCARE CONFERENCE
Jean-Philippe Combal, Vivet Therapeutics’ CEO, and Thomas Daniel, BD Director, will be hosting 1×1 meetings during Jefferies 2020 London Healthcare Conference on November 17-19.
VIVET PRESENTING DURING 2020 4th ANNUAL GENE THERAPY FOR RARE DISORDERS EUROPE CONFERENCE
Anne Douar, Chief Development Officer of Vivet Therapeutics, will give a presentation
VIVET ATTENDING CHARDAN’S 4th ANNUAL GENETIC MEDICINES CONFERENCE
VIVET ATTENDING CHARDAN’S 4th ANNUAL GENETIC MEDICINES CONFERENCE
VIVET IS PARTICIPATING TO THE HEALTHTECH INNOVATION DAYS 2020 (HTID) IN PARIS
VIVET ATTENDING THE HEALTHTECH INNOVATION DAYS (HTID) IN PARIS
VIVET IS PARTICIPATING TO THE PAEDIATRIC CHOLESTASIS WORKSHOP – PART ONE 2020
Bernard Benichou Vivet Therapeutics’ CMO will be participating to a panel and Jean-Philippe Combal, CEO and Sonia Valero, Head of Clinical Operations…
Vivet Therapeutics Announces 2 Abstracts Presentation At 2020 ASGCT Annual Meeting
Vivet Therapeutics, a privately held gene therapy biotech company
